DHA omega-3 may improve chemotherapy outcomes: Study: "Supplements of the omega-3 fatty acid docosahexaenoic acid (DHA) may improve outcomes for breast cancer patients undergoing chemotherapy, says a new study from France.
A daily dose of 1.8 grams of DHA also produced no adverse effects, according to a new study published in the British Journal of Cancer.
“Our data show for the first time that a dietary intervention targeted on DHA is a feasible approach that has potential to substantially increase survival in metastatic breast cancer patients treated with chemotherapy,” wrote the researchers, led by Dr Philippe Bougnoux.
Thursday, February 11, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment